Xiaoli Yu

机构：Drug Discovery Laboratory (Norway), Pharmaceutical Biotechnology (Czechia), Zhejiang University

发表论文 13 篇 · 总被引 85 次 · h-index 6

代表论文

• Auto-RapTAC: A Versatile and Sustainable Platform for the Automated Rapid Synthesis and Evaluation of PROTAC (2025 · Journal of Medicinal Chemistry · 被引 18)
• Structure-based identification of new orally bioavailable BRD9-PROTACs for treating acute myelocytic leukemia (2023 · European Journal of Medicinal Chemistry · 被引 15)
• Progress in the treatment of malignant ascites (2023 · Critical Reviews in Oncology/Hematology · 被引 12)
• Discovery of a potential hematologic malignancies therapy: Selective and potent HDAC7 PROTAC degrader targeting non-enzymatic function (2025 · Acta Pharmaceutica Sinica B · 被引 11)
• Discovery ofaSelective and Potent BCL6 PROTAC withEfficacious Antiproliferative Activity for the Treatment of DiffuseLarge B-Cell Lymphoma (2025 · Journal of Medicinal Chemistry · 被引 7)
• Modular PROTAC/IMiDBifunctional Molecule Design forthe Degradation of Synergistic Targets in the Treatment of Lymphoma (2025 · Journal of Medicinal Chemistry · 被引 6)